On how to find multibaggers you may go through talks given by Hiteshbhai which is referred in this post. Hitesh portfolio – #7635 by barathmukhi
Sterling Holiday Resorts launches new property in Lonavala (08-10-2024)
Sterling Holiday Resorts announced the launch of Sterling Stolen Heaven Lonavala, a condo-styled resort nestled in Karla on the outskirts of the picturesque hill station of Lonavala, Maharashtra. Strategically located near the iconic Bhaja Caves and Karla Caves, the resort is located amidst a sprawling 80 acres of greenery with over 15,000 trees with an Air Quality Index of 11 – providing a green lung-space for guests from Mumbai and Pune.
Torrent Power receives LoA from MSEDCL (08-10-2024)
For long term supply of 2,000 MW Energy Storage Capacity from Torrent Power’s InSTS Connected Pumped Hydro Storage Plant
Discount brokers to be impacted most by new F&O regulations: CRISIL (08-10-2024)
Discount brokerages, such as Zerodha and Groww, will be impacted the most by the recent regulatory moves to curb investors’ derivatives play, domestic rating agency Crisil said on Tuesday.
The agency’s director Subha Sri Narayanan said up to 80 per cent of a discount broker’s revenue comes from derivative trades, while for the full-service brokerages, the same is under a third of the revenues.
“With a relatively low proportion of other revenue streams currently and the more stringent eligibility criteria for retail customers now, discount brokers, who cater predominantly to the retail segment, could see the largest impact, with new customer acquisition also slowing,” Narayanan said.
Its associate director Aesha Maru said competitive dynamics will constrain the discount brokers’ ability to hike brokerage charges, which can otherwise be a mitigant in the face of troubles.
The agency said capital markets regulator Sebi’s revised Equity Index Derivatives Framework announced on October
CRISIL expects 25% hit on discount brokers’ PBT over regulatory changes (08-10-2024)
The market regulator’s mandate on uniform transaction charges or true-to-label norms, exchanges have removed the rebate benefit available to discount brokers in the previous slab-wise rates
Aurigene Oncology receives nod for Phase 2 clinical trial for Ribrecabtagene autoleucel (08-10-2024)
Aurigene Oncology, a wholly-owned subsidiary of Dr. Reddy’s Laboratories has announced the Phase 1 results for Ribrecabtagene autoleucel (DRL-1801) from the SWASTH study – India’s first trial for a novel autologous BCMA directed CAR-T cell therapy in patients with relapsed / refractory multiple myeloma.